1-4 of 4
Salih Demir, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FOXO1 Is Involved in the Regulation of B-Cell Precursor Acute Lymphoblastic Leukemia Survival and Serves As a Novel Target for Directed Therapy

Salih Demir, MSc, Fan Wang, Franziska Gehringer, Clarissa Weitzer, Klaus-Michael Debatin, MD PhD, Thomas Wirth, Prof. Dr., Lüder Hinrich Meyer, MD, Alexey Ushmorov, Dr.
Journal: Blood
Blood (2016) 128 (22): 4020.
https://doi.org/10.1182/blood.V128.22.4020.4020
Published: 2016
Journal Articles

Anti-Leukemia Activity of the Selective BCL-2 Inhibitor ABT-199 in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia Is Characterized By MCL-1/BCL-2 Expression Serving As Biomarker for Treatment Response

Felix Seyfried, MD, Salih Demir, MSc, Rebecca Hörl, Stefan Köhrer, Annika Scheffold, Stephan Stilgenbauer, Klaus-Michael Debatin, MD PhD, Lüder Hinrich Meyer, MD
Journal: Blood
Blood (2016) 128 (22): 1081.
https://doi.org/10.1182/blood.V128.22.1081.1081
Published: 2016
Journal Articles

Synergistic Activity of ABT-199 with Conventional Chemotherapy and Dinaciclib in B-Cell Precursor Acute Lymphoblastic Leukemia

Felix Seyfried, Salih Demir, MSc, Klaus-Michael Debatin, MDPhD, Lueder Hinrich Meyer, MD
Journal: Blood
Blood (2015) 126 (23): 2631.
https://doi.org/10.1182/blood.V126.23.2631.2631
Published: 2015
Journal Articles

Targeting Mutant p53 in Pediatric Acute Lymphoblastic Leukemia

Salih Demir, MSc, Galina Selivanova, PhD, Eugen Tausch, MD, Lisa Wiesmüller, PhD, Stephan Stilgenbauer, MDPhD, Geertruy Te Kronnie, PhD, Klaus-Michael Debatin, MDPhD, Lüder Hinrich Meyer, MD
Journal: Blood
Blood (2015) 126 (23): 903.
https://doi.org/10.1182/blood.V126.23.903.903
Published: 2015